medigraphic.com
ISSN 1561-2937 (Print)

2022, Number 3

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2022; 28 (3)

Electrical complications in patients with ST-segment elevation acute myocardial infarction

Benavides MEM, Hernández VD, Aguiar PJE

Language: Spanish
References: 32
Page: 1-7
PDF size: 870.40 Kb.


ABSTRACT

Introduction: Cardiovascular diseases are the primary cause of death in developed and developing countries, being the acute myocardial infarction and its complications its greatest expression.
Objective: To characterize patients with electrical complications of ST-segment elevation acute myocardial infarction admitted in the Coronary Intensive Care Unit of the Institute of Cardiology and Cardiovascular Surgery from October 2015 to 2017.
Methods: Descriptive, cross-sectional study of the medical records of 60 patients hospitalized in the Coronary Intensive Care Units in the Institute of Cardiology and Cardiovascular Surgery.
Results: In the anterior extensive infarction, 25 % of the cases had ventricular tachycardia and atrial fibrillation. Sinus bradycardia prevailed in cases of inferior myocardial infarction with or without right ventricle involvement, representing 33.3 % and 17.6%, respectively. Ventricular fibrillation (50 %) was the arrhythmia with the highest mortality; 3rd-degree atrioventricular block, atrial fibrillation, and ventricular tachycardia prevailed in the fibrinolytic reperfusion treatment (80.0 %; 75.0 % y 62.5 %, respectively).
Conclusions: Mortality was related to the development of malignant ventricular arrhythmia. Atrial fibrillation, ventricular tachycardia, and ventricular fibrillation remain challenges in the care protocols.


REFERENCES

  1. Ferreira I. Epidemiología de la enfermedad coronaria. Rev. Esp. Cardiol. 2014 [acceso 04/02/2019];2(67):139-44. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-0300893213004855.pdf?locale=es_ES&searchIndex=

  2. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation. The Task Force on the management of ST segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2018 [acceso 19/02/2018];39(2):119-77. Disponible en: https://academic.oup.com/eurheartj/article-pdf/39/2/119/23289187/ehx393.pdf

  3. Norris CM, Johnson NL, Hardwicke-Brown E, McEwan M, Pelletier R, Pilote L. The Contribution of Gender to Apparent Sex Differences in Health Status Among Patients with Coronary Artery Disease. Journal of Women’s Health. 2017 [acceso 19/01/2017];26(1):50-7 Disponible en: https://www.aaojournal.org/article/S0022-5223%2814%2901789-9/fulltext

  4. 4.Go AS, Mozaffarian D, Roger VL, Benjamín EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013 [acceso 23/02/2018];127:143-52. Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIR.0b013e318282ab8f

  5. Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud 2016. La Habana: MINSAP; 2017 [acceso 06/07/2018]; 27-114. Disponible en: http://files.sld.cu/dne/files/2017/05/Anuario_Estad%C3%ADstico_de_Salud_e_2016_edici%C3%B3n_2017.pdf

  6. Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, Shalhoub J. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009. Circulation. 2016;133:1916-26. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.01893 .

  7. Aranda P, González M, Gutiérrez J. Infarto agudo de miocardio y sus complicaciones. ¿Cuáles son las indicaciones quirúrgicas actuales? Cardiocore. 2011[acceso 20/03/2018];46(2):61-4. Disponible en: https://www.redalyc.org/pdf/2770/277021994012.pdf

  8. Gorenek B, Blomstrom Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force [abstract]. Europace. 2014 [acceso 25/01/2015];16(11): [aprox. 2 p.]. Disponible en: https://academic.oup.com/europace/article-abstract/16/11/1655/2483548?redirectedFrom=fulltext

  9. Sheldon RS, Grubb BP, Olshansky B, Win-Kuang S, Calkins H, Brignole, M, et al. Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 [acceso 25/01/2018];12(6):e41-e63. Disponible en: https://www.heartrhythmjournal.com/article/S1547-5271(15)00328-8/pdf

  10. Hernández CG, González VM, Fernández ML, Infante PO. Actitud ante la muerte en los Médicos de Familia. Rev Cub Med Gen Integr. 2012[acceso 23/01/2018] 18(1):22-32. Disponible en: https://www.isciii.es/QuienesSomos/CentrosPropios/INVESTEN/Documents/2016_XX_encuentro_Investen_Coruna.pdf

  11. Batra G, Svennblad B, Held C, Jernberg T, Johanson P, Wallentin L, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016 [acceso 23/01/2018];102(12):926–33. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26928408

  12. Liang JJ, Fender EA, Cha YM, Lennon RJ, Prasad A, Barsness GW. Long-term outcomes in survivors of early ventricular arrhythmias after acute ST-elevation and non-ST-elevation myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2016 [acceso 23/01/2018]; 117(5):709–13. Disponible en: https://www.heartrhythmjournal.com/article/S1547-5271%2817%2930298-9/abstract

  13. Sexto Grupo de Trabajo Conjunto de la Sociedad Europea de Cardiología y otras Sociedades sobre Prevención de Enfermedad Cardiovascular en la Práctica Clínica. Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev Esp Cardiol. 2016 [acceso 20/08/2019];69(10):1-87. Disponible en: https://www.revespcardiol.org/es/pdf/90459671/S300/

  14. Batul SA, Gopinathannair R. Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circ J. 2017 [acceso 05/11/2018]47(5):644–62. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614940/

  15. Mehta L, Beckie T, DeVon H, Grines C, Krumholz H, Johnson M, et al. Acute Myocardial Infarction in Women. A Scientific Statement From the American Heart Association. Circulation. 2016 [ acceso 05/03/2019];133(5):[aprox. 9p.]. Disponible en: https://circ.ahajournals.org/content/early/2016/01/25/CIR.0000000000000351

  16. Women and Heart Disease Fact Sheet Atlanta, GA: Centers for Disease Control and Prevention; 2016 [acceso 03/12/2019]: [aprox. 6 p.]. Disponible en: https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_women_heart.htm

  17. Sociedad Argentina de Cardiología. Ellas también se infartan, pero peor. 2016 [acceso 07/04/2019]; [aprox. 2 p]. Disponible en: https://www.sac.org.ar/actualidad/ellas-tambien-se-infartan-pero-peor/

  18. Islas J E, Carrillo G, Juárez VA, Rotberg T, Fabregat JR. Relación entre el BNP y las arritmias en pacientes con síndrome coronario agudo. Med Int Mex. 2007;23(6): 486-92.

  19. Abildstrom SZ, Jensen BT, Agner E, Torp-Podersen C, Nyvad O, Wachtell K, et al. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol. 2003[acceso 07/04/2019];14(2):168-73. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/12693499

  20. Abildstrom SZ, Jensen BT, Agner E, Torp-Podersen C, Nyvad O, Wachtell K, et al. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol. 2003 [acceso 07/04/2019]; 14(2):168-73. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/12693499

  21. Zipes D, Camm AJ, Borggrefe M, Buxton A, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2006[acceso 05/05/2019]; 48(5):e247-346. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/16949478

  22. Olivera AL. Reperfusión coronaria en el infarto agudo del miocardio con elevación del segmento ST: importancia del contexto y tiempo de aplicación. MEDISAN. 2015 [acceso 06/06/2019]; 19(10): [aprox. 5p]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015001000011

  23. Sgarbossa E, Pinski SL, Barbagelata A, Underwood D, Gates K, Topol EJ, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) investigators. N Engl J Med. 1996 [acceso 26/07/2019];334(8):481-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/8559200

  24. Toledo CI, Iraola M, García R. Causas extrahospitalarias que limitan el uso de trombolíticos en pacientes con infarto cardíaco. 2010[acceso 20/05/2019]:[aprox 7 p]. Disponible en: https://www.sld.cu/galerias /pdf/sitios/urgencia /060

  25. Mehta R, Starr A, Lopes R, Hochman J, Widimsky P, Pieper K, et al. For the APEX AMI Investigators Incidence of and Outcomes Associated with Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention. JAMA. 2009[acceso 26/07/2019]; 301(17):1779-89. Disponible en: https://www.researchgate.net/publication/24403405_Incidence_of_and_Outcomes_Associated_With_Ventricular_Tachycardia_or_Fibrillation_in_Patients_Undergoing_Primary_Percutaneous_Coronary_Intervention

  26. Miller JM, Zipes DP. Tratamiento de las arritmias cardíacas. En: Rodríguez PL, editores. Braunwald's Heart Disease: A textbook of cardiovascular Medicine. 10ma ed. Barcelona: ELSEVIER, 2016; p.11-29.

  27. Schleifer JW, Sorajja D, Shen W. Advances in the pharmacologic treatment of ventricular arrhythmias. Expert Opin Pharmacother. 2015 [acceso 26/07/2018];16(17):2637–51. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26513538

  28. Kudenchuk PJ, Brown SP, Daya M, Rea T, Nichol G, Morrison LJ, et al. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med. 2016 [acceso 06/02/2018];374(18):1711-22. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27043165

  29. Burke MC, Gold MR, Knight BP, Barr CS, Theuns DA, Boersma LV, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator. J Am Coll Cardiol. 2015 [acceso 06/07/2019];65(16):1605–15. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0735109715007573.pdf?locale=es_ES&searchIndex=

  30. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation. Eur Heart J. 2012 [acceso 06/07/2019];33(20):2569-619. Disponible en: https://academic.oup.com/eurheartj/article/33/20/2569/447818

  31. Chatterjee S, Chaudhuri D, Vedanthan R, Fuster V, Ibanez B, Bangalore S, et al. Early intravenous beta-blockers in patients with acute coronary síndrome - a meta-analysis of randomized trials. Int J Cardiol. 2013 [acceso 26/06/2019];168(2):915–21. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0167527312014258.pdf?locale=es_ES&searchIndex=

  32. Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Flather MD. Beta-Blockers in Heart Failure Collaborative Group. beta blockers in patients with heart failure and atrial fibrillation. Lancet. 2014 [acceso 26/06/2019];38(9961): 2235–43. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0140673614613738.pdf?locale=es_ES&searchIndex=




2020     |     www.medigraphic.com